Investment Advisory Board

The Investment Advisory Board advises Harrington Discovery Institute leadership on the institute’s post-award investment decisions. The panel’s decades of industry and venture funding experience help to advance promising scholar projects and ensure the strength of Harrington Discovery Institute’s portfolio.

John Rice, PhD, Chair

Managing Partner, Triathlon Medical Ventures

Former Managing Director of Senmed Medical Ventures

June Almenoff, MD, PhD

Executive-in-Residence, Hatteras Venture Partners

Former President, Chief Medical Officer, Furiex Pharmaceuticals

Stephen Burley, MD, PhD

Chief Scientific Officer, SGX Pharma

Distinguished Professor of Chemistry, Rutgers University

Nancy Chang, PhD

Co-founder, Tanox

Former President, Chief Executive Officer and Chairman of the Board, Tanox

Peter Grebow, PhD

President, P.E. Grebow Consulting, Inc.

Former Executive VP of Cephalon Ventures

Graeme R. Martin, PhD

Chief Investment Officer, ALSA Ventures

Former President & CEO, Takeda Ventures, Inc.

Jesse Treu, PhD

Partner, Domain Associates

Vice President, CW Ventures